United Kingdom · Question · Written question
UIN 72985
Prescription Drugs: Prices
Introduced
27 October 2022
Last action
1 November 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 November 2022
Summary
To ask the Secretary of State for Health and Social Care, with reference to the CMA's press release entitled CMA fines pharma firm over pricing of crucial thyroid drug, published on 29 July 2022, what steps he is taking to prevent extreme price gouging; a
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
27 October 2022
Written question
To ask the Secretary of State for Health and Social Care, with reference to the CMA's press release entitled CMA fines pharma firm over pricing of crucial thyroid drug, published on 29 July 2022, what steps he is taking to prevent extreme price gouging; a
Source: Commons
1 November 2022
Answer
The costs of branded medicines are controlled by the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and the statutory scheme for branded medicines. For unbranded generic medicines, the Department encourages competition between suppliers ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-10-27/72985
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1536731
- uk · wq-1536731 · source updated 1 November 2022